SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being ...

Ontada is highlighting its research capabilities at ASH with nine accepted abstracts on topics such as real-world uptake and patient characteristics of bispecific antibodies in relapsed / refractory ...

RWJBarnabas Health's commitment to enhancing access to care includes a transformative partnership with Rutgers University, including the Rutgers Cancer Institute -- the state's only NCI-designated ...

Perioperative enfortumab vedotin and pembrolizumab added to surgery may represent a new standard of care in this population with a high unmet medical need,” said Christof Vulsteke, MD, PhD.

Patients in the highest-exposure group, ie, those with more than 385 defined daily doses of PPIs, have an 83% higher risk for gastric neuroendocrine tumors than nonusers.

We know that genetics, cigarettes, and sunbathing can cause cancer, but you can also develop cancer due to materials you ...

Yellapragada Subbarow, an Indian biochemist, developed the biochemical basis for chemotherapy. Despite his vital ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsWilliam Meury - CEO, ...

AbbVie (NYSE: ABBV) today announced it will unveil new data at the 2025 American Society of Hematology (ASH) Congress, showcasing continued advances in research across multiple blood cancers including ...

Medically reviewed by Suzanne Fisher, RD Key Takeaways Chili combines several healthy foods, including beans, lean protein, tomatoes, vegetables, and spices. However, some chili additions, like red ...

Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic vascular disorder (prevalence 1 in 3,800) characterized by recurrent severe epistaxis, anemia, and visceral arteriovenous malformations ...

Opdivo (nivolumab), in combination with Yervoy (ipilimumab), is indicated for the treatment of adult and paediatric patients 12 years and older with unresectable or metastatic microsatellite ...